Literature DB >> 27423586

Neuromuscular complications in cancer.

W Grisold1, A Grisold2, W N Löscher3.   

Abstract

Cancer is becoming a treatable and even often curable disease. The neuromuscular system can be affected by direct tumor invasion or metastasis, neuroendocrine, metabolic, dysimmune/inflammatory, infections and toxic as well as paraneoplastic conditions. Due to the nature of cancer treatment, which frequently is based on a DNA damaging mechanism, treatment related toxic side effects are frequent and the correct identification of the causative mechanism is necessary to initiate the proper treatment. The peripheral nervous system is conventionally divided into nerve roots, the proximal nerves and plexus, the peripheral nerves (mono- and polyneuropathies), the site of neuromuscular transmission and muscle. This review is based on the anatomic distribution of the peripheral nervous system, divided into cranial nerves (CN), motor neuron (MND), nerve roots, plexus, peripheral nerve, the neuromuscular junction and muscle. The various etiologies of neuromuscular complications - neoplastic, surgical and mechanic, toxic, metabolic, endocrine, and paraneoplastic/immune - are discussed separately for each part of the peripheral nervous system.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cranial nerves; Leukemia; Lymphoma; Muscle; Neuromuscular complications; Neuromuscular junction; Peripheral nerves

Mesh:

Year:  2016        PMID: 27423586     DOI: 10.1016/j.jns.2016.06.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment.

Authors:  Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey
Journal:  Eur J Appl Physiol       Date:  2020-04-06       Impact factor: 3.078

2.  Results From a Pilot Study of Handheld Vibration: Exercise Intervention Reduces Upper-Limb Dysfunction and Fatigue in Breast Cancer Patients Undergoing Radiotherapy: VibBRa Study.

Authors:  Sarah Kneis; Anja Wehrle; Anne Ilaender; Natalja Volegova-Neher; Albert Gollhofer; Hartmut Bertz
Journal:  Integr Cancer Ther       Date:  2018-04-16       Impact factor: 3.279

3.  Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol.

Authors:  A Rahmani; B Morel; M Chartogne; A Leclercq; B Beaune; S Boyas; C Forestier; T Martin; V Thomas-Ollivier; S Landry; H Bourgeois; O Cojocarasu; V Pialoux; O Zanna; L A Messonnier
Journal:  BMC Cancer       Date:  2021-10-23       Impact factor: 4.430

Review 4.  CD20-positive subcutaneous panniculitis-like T-cell lymphoma presenting as polycranial neuropathy: A CARE-compliant case report and literature review.

Authors:  Jing Xu; Jia Li; Ya-Juan Sun; Wei Quan; Li Liu; Qing-Hui Zhang; Yi-Dan Qin; Xiao-Chen Pei; Hang Su; Jia-Jun Chen
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

5.  Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial.

Authors:  Rosie Twomey; Tristan Martin; John Temesi; S Nicole Culos-Reed; Guillaume Y Millet
Journal:  BMC Cancer       Date:  2018-07-24       Impact factor: 4.430

Review 6.  Paraneoplastic neurological syndrome: an evolving story.

Authors:  Jiraporn Jitprapaikulsan; Pritikanta Paul; Smathorn Thakolwiboon; Shivam Om Mittal; Sean J Pittock; Divyanshu Dubey
Journal:  Neurooncol Pract       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.